Abstract
Background. Meningiomas often harbor an immune cell infiltrate that can include substantial numbers of T and B cells. However, their phenotype and characteristics remain undefined. To gain a deeper understanding of the T and B cell repertoire in this tumor, we characterized the immune infiltrate of 28 resected meningiomas representing all grades. Methods. Immunohistochemistry was used to grossly characterize and enumerate infiltrating lymphocytes. A molecular analysis of the immunoglobulin variable region of tumor-infiltrating B cells was used to characterize their antigen experience. Flow cytometry of fresh tissue homogenate and paired peripheral blood lymphocyteswasused to identifyTcell phenotypesandcharacterize the T cell repertoire. Results. A conspicuous B and T cell infiltrate, primarily clustered in perivascular spaces, was present in the microenvironment of most tumors examined. Characterization of 294 tumor-infiltrating B cells revealed clear evidence of antigen experience, in that the cardinal features of an antigen-driven B cell response were present.Meningiomas harbored populations of antigen-experienced CD4+ and CD8+ memory/effector T cells, regulatory T cells, and T cells expressing the immune checkpoint molecules PD-1 and Tim-3, indicative of exhaustion. All of these phenotypeswere considerably enriched relative to their frequency in the circulation. The T cell repertoire in the tumor microenvironmentincludedpopulationsthatwerenot reflected in paired peripheral blood. Conclusion. The tumor microenvironment of meningiomas often includes postgerminal center B cell populations. These tumors invariably include a selected, antigen-experienced, effector T cell population enriched by those that express markers of an exhausted phenotype.
Original language | English |
---|---|
Pages (from-to) | 1479-1490 |
Number of pages | 12 |
Journal | Neuro-Oncology |
Volume | 15 |
Issue number | 11 |
DOIs | |
State | Published - 1 Nov 2013 |
Externally published | Yes |
Keywords
- B cell
- Meningioma
- T cell
- Tumor-infiltrating lymphocytes